Idorsia Pharmaceuticals US Inc

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.

Braeburn Inc. is a Plymouth Meeting, PA-based company dedicated to addressing opioid use disorder through innovative products and community advocacy. With a strong focus on outreach, they aim to foster connections and support for individuals and families affected by substance use challenges. The organization emphasizes collaboration and partnerships to enhance the delivery of medicines and medical devices to U.S. patients. In addition, Braeburn actively participates in community initiatives, showcasing personal stories and promoting recovery-focused resources to reduce stigma around addiction. Generated from the website

Trevena, Inc is an innovative biopharmaceutical company based in Chesterbrook, PA, dedicated to developing groundbreaking medicines for patients with central nervous system (CNS) disorders. Their pipeline includes one FDA-approved product, OLINVYK oliceridine injection, and three differentiated investigational drug candidates, targeting various therapeutic areas such as acute pain, diabetic neuropathic pain, epilepsy, acute migraine, and opioid use disorder. With a focus on targeted and innovative CNS therapies, Trevena's pipeline is built on Nobel Prize-winning research and aims to address the critical needs of patients. Their commitment to innovation and patient care drives their mission to deliver effective treatments for CNS disorders.Generated from the website